News
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
The country’s Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, the UK’s official system for ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...
You've heard about the likes of Ozempic, Wegovy and Mounjaro, jabs which a growing number of people are taking in an attempt ...
A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...
Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs can’t do? While a medicine that reverses the clock would be a ...
Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...
India is among the top two countries in terms of type 2 diabetes cases and third in terms of obesity; hence, the need for ...
A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results